These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10787239)

  • 1. Are Mpl glycosylation defects in polycythemia vera secondary to artifactual hypoglycemia?
    Otto KG
    Blood; 2000 Apr; 95(7):2452. PubMed ID: 10787239
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic approaches to polycythemia vera in 2004.
    Pahl HL
    Expert Rev Mol Diagn; 2004 Jul; 4(4):495-502. PubMed ID: 15225097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.
    Moliterno AR; Spivak JL
    Blood; 1999 Oct; 94(8):2555-61. PubMed ID: 10515857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis.
    Tefferi A; Yoon SY; Li CY
    Blood; 2000 Jul; 96(2):771-2. PubMed ID: 10887148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel thrombopoietin signaling defect in polycythemia vera platelets.
    Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
    Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera.
    Le Blanc K; Andersson P; Samuelsson J
    Br J Haematol; 2000 Jan; 108(1):80-5. PubMed ID: 10651727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction in platelets from patients with polycythemia vera.
    Lange W; Martens UM; Waller CF
    N Engl J Med; 1998 Jul; 339(2):127-8. PubMed ID: 9669902
    [No Abstract]   [Full Text] [Related]  

  • 9. Polycythemia vera--chance, death, and mutability.
    Schwartz RS
    N Engl J Med; 1998 Feb; 338(9):613-5. PubMed ID: 9475771
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
    Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
    J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia rubra vera and artifactual hypoglycemia.
    Arem R; Jeang MK; Blevens TC; Waddell CC; Field JB
    Arch Intern Med; 1982 Nov; 142(12):2199-201. PubMed ID: 7138167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a molecular understanding of polycythemia rubra vera.
    Pahl HL
    Eur J Biochem; 2000 Jun; 267(12):3395-401. PubMed ID: 10848954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin and its receptor, the proto-oncogene c-mpl.
    Wendling F; Vainchenker W
    Curr Opin Hematol; 1995 Sep; 2(5):331-8. PubMed ID: 9372016
    [No Abstract]   [Full Text] [Related]  

  • 14. Artifactual hypoglycemia associated with polycythemia vera.
    Billington CJ; Casciato DA; Choquette DL; Morley JE
    JAMA; 1983 Feb; 249(6):774-5. PubMed ID: 6823031
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated thrombopoietin levels and alterations in the sequence of its receptor, c-Mpl, in patients with Diamond-Blackfan anemia.
    Pospisilova D; Cmejlova J; Slavik L; Cmejla R
    Haematologica; 2004 Nov; 89(11):1391-2. PubMed ID: 15531462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemia.
    Pahl HL
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):202, 204. PubMed ID: 16163180
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
    Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
    Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TPO/c-mpl and hematopoietic stem cells].
    Matsumura I; Kanakura Y
    Nihon Naika Gakkai Zasshi; 1999 Dec; 88(12):2487-92. PubMed ID: 10630014
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.